Clinical Trials Browser

Phase 2 × OTHER_GOV × Control Groups × Clear all

NCT04222790 2023-12-04

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Phase 2 Completed

Breast Neoplasms